Cargando…

Calcifediol (25OHD) Deficiency and Its Treatment in Women’s Health and Fertility

Currently, there is abundant scientific evidence showing that the vitamin D endocrine system (VDES) is a highly complex endocrine system with multiple actions in different regions of the body. The unequivocal presence of vitamin D receptors in different tissues related to fertility, and to specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnanz, Ana, Garcia-Velasco, Juan A., Neyro, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103696/ https://www.ncbi.nlm.nih.gov/pubmed/35565788 http://dx.doi.org/10.3390/nu14091820

Ejemplares similares

25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics
por: Castano, Luis, et al.
Publicado: (2022)

Calcifediol in the management of vitamin D deficiency-related skeletal and extraskeletal diseases: overview and clinical cases
por: Casado, Enrique, et al.
Publicado: (2023)

Associations of Serum Total 25OHD, 25OHD3, and epi-25OHD3 with Insulin Resistance: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey, 2011–2016
por: Zhou, Meiling, et al.
Publicado: (2022)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020)

Treatment of Vitamin D Deficiency with Calcifediol: Efficacy and Safety Profile and Predictability of Efficacy
por: Pérez-Castrillon, Jose-Luis, et al.
Publicado: (2022)

Calcifediol for Use in Treatment of Respiratory Disease
por: Entrenas-Castillo, Marta, et al.
Publicado: (2022)

Calcifediol: Mechanisms of Action
por: Donati, Simone, et al.
Publicado: (2023)

Calcifediol (25OH Vitamin D(3)) Deficiency: A Risk Factor from Early to Old Age
por: Bouillon, Roger, et al.
Publicado: (2022)

Lower 25-hydroxyvitamin D (25OHD) levels, diabetes and age are associated with foot and ankle fracture treatment complications
por: Bertelli, Hallan Douglas, et al.
Publicado: (2023)

Vitamin D (25OHD) Serum Seasonality in the United States
por: Kasahara, Amy K., et al.
Publicado: (2013)

Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2022)

Calcifediol: a review of its pharmacological characteristics and clinical use in correcting vitamin D deficiency
por: Jodar, Esteban, et al.
Publicado: (2023)

Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation
por: Mingiano, Christian, et al.
Publicado: (2023)

Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2021)

Sun exposure, ultraviolet (UV) irradiance and serum 25 hydroxycholecalciferol (25OHD) in pregnant women in rural North India
por: Sudhanshu, Siddhnath, et al.
Publicado: (2015)

Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women
por: Sosa‐Henríquez, Manuel, et al.
Publicado: (2022)

Calcifediol Cornerstone of the Vitamin D Endocrine System
por: Quesada-Gomez, Jose Manuel, et al.
Publicado: (2023)

Rapid Nontranscriptional Effects of Calcifediol and Calcitriol
por: Donati, Simone, et al.
Publicado: (2022)

Calcifediol: Why, When, How Much?
por: Donati, Simone, et al.
Publicado: (2023)

Data in support for the measurement of serum 25-hydroxyvitamin D (25OHD) by tandem mass spectrometry
por: Jensen, M.E., et al.
Publicado: (2016)

25-hydroxyvitamin D (25-OHD) levels in Turkish geriatric population: A nationwide study
por: Çağlayan, Murat, et al.
Publicado: (2022)

Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
por: Pérez‐Castrillón, José Luis, et al.
Publicado: (2021)

Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol?
por: Cesareo, Roberto, et al.
Publicado: (2019)

LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity
por: Strugnell, Stephen A, et al.
Publicado: (2022)

LBSAT131 Extended-release Calcifediol Reduced Ipth And Normalized 1,25-dihydroxyvitamin D In Esrd.
por: Ashfaq, Akhtar, et al.
Publicado: (2022)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis
por: Afifi, Mohamed Abd Ellatif, et al.
Publicado: (2021)

25OHD analogues and vacuum blood collection tubes dramatically affect the accuracy of automated immunoassays
por: Yu, Songlin, et al.
Publicado: (2015)

Prognostic Relevance of Circulating 25OHD Fractions for Early Recovery and Survival in Patients with Hip Fracture †
por: Toldy, Erzsébet, et al.
Publicado: (2018)

Bariatric surgery and calcifediol treatment, Gordian knot of severe-obesity-related comorbidities treatment
por: Herrera-Martínez, Aura D., et al.
Publicado: (2023)

Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?
por: Pasquali, Marzia, et al.
Publicado: (2015)

Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
por: Cruzado, Josep M., et al.
Publicado: (2017)

In Vitro Non-Genomic Effects of Calcifediol on Human Preosteoblastic Cells
por: Donati, Simone, et al.
Publicado: (2021)

Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children
por: Braithwaite, V.S., et al.
Publicado: (2015)

Appropriate Cutoff for 25OHD Levels in the Diagnosis of Normocalcemic Primary Hyperparathyroidism (NPHPT): A Systematic Review
por: Yedla, Niharika, et al.
Publicado: (2021)

Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer
por: Hawkins Carranza, Federico, et al.
Publicado: (2020)

Concentrations of total, bioavailable, and free 25OHD in individuals with and without primary hyperparathyroidism and their correlations to DXA and trabecular bone score
por: Santos, Lívia Marcela, et al.
Publicado: (2023)

Normal fertilisation rates and serum 25-OHD levels among couples undergoing in-vitro fertilisation: a prospective cohort study
por: Jiang, Liu, et al.
Publicado: (2020)

The Vitamin D Receptor (VDR) Is Expressed in Skeletal Muscle of Male Mice and Modulates 25-Hydroxyvitamin D (25OHD) Uptake in Myofibers
por: Girgis, Christian M., et al.
Publicado: (2014)

A prospective analysis of concentration of 25-OHD between northern and southern district in Japan in year-round study
por: Horikawa, Akira, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uhoaqb4ei4o1kvfcdbqilqh776